Medica announces the acquisition of Global Diagnostics Ireland, expanding its geographic reach, customer base and service offering. Global Diagnostics is the market leader for teleradiology services in Ireland.
Headquartered in Balally, Dublin, Global Diagnostics Ireland operate c. 50 clinical sites across Ireland and employ c. 140 staff nationwide, with an experienced team delivering a high quality, professional service. For Medica this acquisition represents a diversification of customer base, geographical operations and an entry into a new service area of ophthalmology and retinopathy screening services.
Global Diagnostics Ireland is comprised of two businesses:
is focused on provision of teleradiology and radiology imaging managed services to both public and private healthcare organisations.
provides Diabetic Retinopathy Screening and Surveillance services on behalf of the National Screening Service in Ireland.
Dr. Stuart Quin, CEO of Medica Group stated:
“We have been evaluating the Irish market for teleradiology for the past year and in GDI we have found an ideal partner that shares our focus to provide the highest quality radiology services. GDI has built a strong reputation amongst radiologists, as well as hospital and primary care clients across Ireland. Additionally, in partnership with leading ophthalmologists in Ireland, they have built a strong reputation in the delivery of diabetic retinopathy screening services which cover 50% of the Irish market. Medica will support Caroline and the management team to continue to grow and develop the business, as well as invest to deliver a broader range of services.”
Caroline Byrne, who will join the Medica executive team as Managing Director, Ireland, commented:
“We are excited to join forces with Medica and think it will benefit all our stakeholders. Ireland’s teleradiology market is attractive and evolving at a pace whereby we will benefit from the processes, systems and clinical governance expertise that Medica brings. In addition to the strong business rationale for both parties, we also see a close cultural fit between our two organisations and we look forward to continuing to develop the Company for the benefit of our clients and their patients.”
For further information on the transaction, please click here.
About Medica Group PLC
Medica is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting of MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers two primary services to hospital radiology departments:
- NightHawk, urgent reporting service
- Elective which includes routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.
Medica contracts with the largest pool of consultant radiologists in the UK performing remote access teleradiology across its customer base of more than 100 NHS Trusts, private hospital groups and diagnostic imaging companies in the UK. This enables the Company to offer a fast, responsive service both during the day and importantly supporting urgent out-of-hours reporting.
Medica has developed a bespoke, secure IT platform that provides market-leading linkage between a hospital’s Radiology Information System (RIS) and consultant radiologists who contract with the Company. Direct RIS access ensures that where the wider patient medical history is available, it can be reviewed by the consultant as part of every report. For more information please visit www.medica.co.uk
About Global Diagnostics:
Global Diagnostics is an award-winning radiology services provider in Ireland. They deliver bespoke managed service solutions to public and private hospitals, and have direct to patient services in MRI, Ultrasound, CT, DXA and X-Ray under the Medical Directorship of Consultant Radiologist Dr Derek Lohan. Their clients range from large tertiary hospitals to small standalone medical facilities.
For more information please visit https://www.globaldiagnostics.ie/
About Global Vision:
Global Vision is a Digital Photography and Grading Services Provider for the HSE National Diabetic Retinal Screening Programme in Ireland. The HSE National Diabetic Retinal Screening Programme, established in 2013, is Government-funded and offers free, annual screening and treatment of diabetic retinopathy, a common complication of diabetes that can lead to deterioration in vision.
Implemented and managed by the National Screening Service (NSS), part of the Health Service Executive (HSE), this call/re-call screening programme aims to reach a growing eligible population of 190,000+ people.
Global Vision is responsible for screening 50% of the eligible population and delivers services from fourteen different screening locations across Dublin, Louth, Meath, Kildare, Offaly, Laois, Carlow, Kilkenny, Wicklow, Wexford and Waterford, under the Clinical Leadership of Consultant Ophthalmologist, Mr Mark Cahill
About teleradiology:
Teleradiology is the remote electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.
About retinal diagnostic screening:
People with both Type 1 and Type 2 diabetes are at risk of developing diabetic retinopathy. This is a common complication of diabetes which affects the small blood vessels in the lining at the back of the eye and can lead to deterioration in vision. Regular diabetic retinopathy screening is recommended for people with diabetes aged 12 years and older.